Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) StudySigne Westring Worm, Jens Lundgren, Caroline Sabin et al.|The Journal of Infectious Diseases|2009Cited by 649
Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs StudyNina Friis‐Møller, Rodolphe Thiébaut, Peter Reiss et al.|European Journal of Cardiovascular Prevention & Rehabilitation|2010Cited by 392
Lipid Profiles in HIV‐Infected Patients Receiving Combination Antiretroviral Therapy: Are Different Antiretroviral Drugs Associated with Different Lipid Profiles?Éric Fontas, Frank van Leth, Caroline Sabin et al.|The Journal of Infectious Diseases|2004Cited by 336
An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) studyNina Friis‐Møller, Matthew Law, Lene Ryom et al.|European Journal of Preventive Cardiology|2015Cited by 237
Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort studyLene Ryom, Amanda Mocroft, Jens Lundgren et al.|The Lancet HIV|2018Cited by 222